Prenetics Global Limited is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Sheng Wu Yeung, with a market cap of $294.8M.
Common questions about Prenetics Global Limited
Prenetics Global Limited is scheduled to report earnings for Q1 2026 on June 11, 2026. Analysts estimate revenue of $37.9M.
Prenetics Global Limited has approximately 320 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.